© 2020 MJH Life Sciences and HCPLive. All rights reserved.
June 30, 2020
Ozanimod could soon be added to the ever growing stable of potential treatments for Crohn’s disease.
June 29, 2020
The FDA recommends additional safety and efficacy data from the ongoing REGENERATE trial.
June 28, 2020
Prior family exposure represented the factor with the second highest IRR behind hospital exposure.
June 24, 2020
The median 12-month risk of clinical relapse in patients with MES 1 was 28.7%, while the estimated annual risk of clinical relapse in patients with a MES 0 was 13.7%.
June 16, 2020
During the induction period, patients in the treatment group had higher incidences of infections and serious infectious compared to placebo.
June 12, 2020
A recent analysis is examining potential factors associated with adverse gastrointestinal events in patients using semaglutide and whether it mitigates benefit.
June 11, 2020
Dr. Vibeke Strand discusses how better treatment of psoriatic arthritis could yield better treatments for NASH.
June 10, 2020
Between 2002-2019, NASH is the leading liver indication for women without HCC.
New recommendations support the use of probiotics for preterm and low birthweight infants to prevent mortality and necrotizing enterocolitis.
June 08, 2020
Dr. Dennis McGonagle said guslekumab is also being tested in patients with inflammatory bowel disease.